Physician profile
Clinton Mclean
NPI 1801995543
$4,245.24
in general payments reported to CMS, 2019-2025
22 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $127 · 2021: $403 · 2022: $464 · 2023: $726 · 2024: $843 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,536 · Entertainment: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.92 |
| Entertainment | $120.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $622.42 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $606.06 | 2022-2025 | Xiidra, Miebo, Infuse |
| Alcon Vision LLC | $555.65 | 2019-2025 | Tryptyr, Eysuvis, Total30 |
| Glaukos Corporation | $490.64 | 2023-2024 | Photrexa, Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished) |
| Tarsus Pharmaceuticals, INC. | $330.55 | 2024-2025 | Xdemvy |
| Coopervision INC. | $314.51 | 2019-2025 | Myday Contact Lens, Ortho-K Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $199.78 | 2019-2021 | |
| Oyster Point Pharma, INC. | $179.42 | 2022-2024 | Ryzumvi, Tyrvaya |
| Novartis Pharmaceuticals Corporation | $135.99 | 2021-2023 | |
| Allergan, INC. | $120.72 | 2019 | |
| Optos, INC. | $120.38 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visioneering Technologies, INC. | $89.27 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $84.52 | 2019 | |
| Abb Con-Cise Optical Group LLC | $76.57 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Sight Sciences, INC. | $66.16 | 2022-2023 | Tearcare System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $65.96 | 2019 | |
| Dompe US, INC. | $56.75 | 2025 | Oxervate |
| Lombart Brothers, INC. | $38.14 | 2019-2021 | |
| Abbvie INC. | $26.74 | 2024 | |
| Sun Pharmaceutical Industries INC. | $26.05 | 2025 | |
| Astellas Pharma US INC | $19.56 | 2024 | Izervay |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.